Basel-Landschaft

EQS-News: Baloise provides pioneering support for Svizra27 feasibility study

Retrieved on: 
Monday, December 20, 2021

The recently announced winning project will now be subject to a feasibility study, which is receiving pioneering support from Baloise, among others.

Key Points: 
  • The recently announced winning project will now be subject to a feasibility study, which is receiving pioneering support from Baloise, among others.
  • Svizra27 sees itself as a project spanning generations that aims to appeal to Swiss people at every stage of their lives.
  • This is why it is supporting the feasibility study, due to be conducted from 2022 to 2023.
  • The feasibility study will now embark on selecting nine locations within the five cantons of Aargau, Basel-Landschaft, Basel-Stadt, Jura and Solothurn in north-western Switzerland.

China based CMS joins BaseLaunch as latest partner

Retrieved on: 
Wednesday, September 22, 2021

CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.

Key Points: 
  • CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.
  • Stephan Emmerth, Director Business Development & Operations at BaseLaunch, added: "We are very excited to be further expanding our partnership into Asia Pacific with CMS.
  • This is the first Chinese company to partner with BaseLaunch and CMS's first partnership with an accelerator.
  • Recently, BaseLaunch has added two more companies to its portfolio with several more deals expected to close in the coming months.

China based CMS joins BaseLaunch as latest partner

Retrieved on: 
Wednesday, September 22, 2021

BASEL, Switzerland, Sept. 22, 2021 /PRNewswire/ -- BaseLaunch, the Basel Area-based biotech venture accelerator and incubator, today announces that China Medical System Holdings Limited ("CMS"), an innovation-driven specialty pharma with a focus on sales and marketing in China, has become a partner to further strengthen BaseLaunch`s industry ties fueling its company building activities.

Key Points: 
  • CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.
  • Stephan Emmerth, Director Business Development & Operations at BaseLaunch, added: "We are very excited to be further expanding our partnership into Asia Pacific with CMS.
  • This is the first Chinese company to partner with BaseLaunch and CMS's first partnership with an accelerator.
  • Recently, BaseLaunch has added two more companies to its portfolio with several more deals expected to close in the coming months.